On Wednesday, Intercontinental Exchange Inc (NYSE:ICE)’s shares declined -0.15% to $243.98.
The New York Stock Exchange, part of the Intercontinental Exchange (ICE) global network of exchanges, remained the leading exchange globally for capital raising in the first half of 2015, with 264 transactions raising a total of $94 billion, more than any other exchange in the world. This comprises 42 companies that raised $12 billion from initial public offerings (IPOs) in the first half of 2015.
With leadership across multiple sectors, NYSE led with 100% of REIT IPOs and 70% of all private equity (PE)-backed IPO proceeds, while gaining momentum in healthcare, counting one of the largest biotech IPOs ever. Compriseent with its leadership in technology IPOs since 2012, the NYSE welcomed 10 technology IPOs raising $2.6 billion, which represents 66% of all capital raised from U.S. tech IPOs. Additionally, more than 85% of exchange traded products (ETPs) listed on NYSE Arca during the first half of the year.
Intercontinental Exchange, Inc. operates a network of regulated exchanges and clearing houses for financial and commodity markets in the United States, the United Kingdom, Continental Europe, Israel, Canada, and Singapore. The company operates marketplaces for trading and clearing a range of securities and derivatives contracts in various asset classes, counting energy and agricultural commodities, interest rates, equities, equity derivatives, credit derivatives, bonds, and currencies. It primarily provides trade execution, listing, price discovery and transparency, trade processing and repositories, clearing, benchmark administration, and market data services .
Covanta Holding Corp (NYSE:CVA)’s shares dropped -1.10% to $20.62.
Covanta Holding Corporation (CVA) stated financial results recently for the three and six months ended June 30, 2015.
Q2 2015 Summary
- Strong operating performance in core business, with all production metrics in line with expectations; successfully executed majority of annual maintenance plan.
- Achieved record quarterly special waste revenue.
- Accomplished acquisition of Advanced Waste Services (AWS) treatment, storage and disposal (TSD) business, expanding environmental services capabilities.
- Formerly declared China equity swap/sale to monetize assets at an attractive value and re-positions the Company for pursuing new opportunities.
- Revising 2015 guidance primarily due to delay in Durham-York facility commissioning.
Covanta Holding Corporation provides waste and energy services to municipal entities primarily worldwide. It owns and operates infrastructure for the conversion of waste to energy, in addition to engages in other waste disposal and renewable energy production businesses. The company is also involved in the disposal of waste and the generation of electricity and/or steam, in addition to in the sale of metal recovered during the energy-from-waste process.
At the end of Wednesday’s trade, Keryx Biopharmaceuticals (NASDAQ:KERX)‘s shares dipped -3.22% to $6.01.
Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease, declared its financial results for the second quarter ended June 30, 2015.
BUSINESS HIGHLIGHTS
Auryxia U.S. Commercialization
- Net U.S. Auryxia product sales for the second quarter were about $1.8 million, based on about 3,700 Auryxia prescriptions, as stated to the company by IMS Health and specialty pharmacies that do not report data to IMS, counting DaVita Rx and Fresenius Rx.
- Unrestricted access for Auryxia raised to 65 percent across Medicare Part D and commercial insurance providers, with the addition of Auryxia on the formularies of two national Part D insurance providers that began processing claims in the third quarter of 2015.
- Keryx’s sales representatives have reached more than 75 percent of the 5,000 prescriber targets; about 1,000 target prescribers have written a prescription for Auryxia.
- Keryx successfully introduced samples into the market in the second quarter, with about 6,000 starter kits shipped to about 1,300 target prescribers — the majority of whom had not formerly prescribed Auryxia.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
GasLog Ltd (NYSE:GLOG), ended its Wednesday’s trading session with -2.45% loss, and closed at $13.95.
GasLog Ltd. (GLOG) declared the completion of the LNGreen joint industry project. The LNGreen joint industry project brought together experts from GasLog, DNV GL, GTT and Hyundai Heavy Industries (“HHI”) to develop a state-of-the-art, next-generation, LNG carrier. Each of the project partners contributed their unique know-how and experience to develop the LNG carrier of tomorrow using the latest technology within the bounds of existing shipbuilding methods. The vessel concept has a significantly improved environmental footprint, a higher level of energy efficiency, an improved boil-off rate, and improved cargo capacity. Applying 2-stroke propulsion technology makes the vessels very well suited to future LNG trading patterns.
The LNGreen project focused on improving the efficiency and performance of the modern LNG carrier by analyzing actual operational performance data, focusing on further optimization through reassessment of vessel hydrodynamics, machinery and systems configuration. These improvements will lead to greater efficiency and cargo capacity without any compromise to the safety or quality of the vessels.
GasLog Ltd., together with its auxiliaries, owns, operates, and manages vessels in the liquefied natural gas (LNG) market worldwide. It provides maritime services for the transportation of LNG; and LNG vessel administration services. As of February 27, 2015, the company operated 20 LNG carriers. It also had 6 LNG carriers operating under its technical administration for third parties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
